Introduction:
By the late-October 2020, more than 42 million confirmed cases of novelCoronavirus disease (Covid-19) and 1.1 million deaths occurred
worldwide (1). Several studies reported the correlation between Covid-19
and inflammatory syndromes, such as Guillain-Barre, myocarditis, and
encephalitis (2-4). Indeed, a significant proportion of mortality and
morbidity in Covid-19 is due to non-pulmonary immune-mediated
complications. These syndromes may affect any organ and have a
significant role in tissue damage and death (5). We reported a patient
with Covid-19 pneumonia, who developed Henoch–Schoenlein purpura (HSP)
on his admission.